BACKGROUND: Nonsmall cell lung cancer (NSCLC) is the major determinant of overall cancer mortality worldwide. Despite progress in molecular research, current treatments offer limited benefits. Because NSCLC generates early metastasis, and this behavior requires great cell motility, herein the authors assessed the potential value of CFL1 gene (main member of the invasion/metastasis pathway) as a prognostic and predictive NSCLC biomarker. METHODS: Metadata analysis of tumor tissue microarray was applied to examine expression of CFL1 in archival lung cancer samples from 111 patients, and its clinicopathologic significance was investigated. The robustness of the finding was validated using another independent data set. Finally, the authors assayed in vitro the role of CFL1 levels in tumor invasiveness and drug resistance using 6 human NSCLC cell lines with different basal degrees of CFL1 gene expression. RESULTS: CFL1 levels in biopsies discriminate between good and bad prognosis at early tumor stages (IA, IB, and IIA/B), where high CFL1 levels are correlated with lower overall survival rate (P<.0001). Biomarker performance was further analyzed by immunohistochemistry, hazard ratio (P<.001), and receiver-operating characteristic curve (area=0.787; P<.001). High CFL1 mRNA levels and protein content are positively correlated with cellular invasiveness (determined by Matrigel Invasion Chamber System) and resistance (2-fold increase in drug 50% growth inhibition dose) against a list of 22 alkylating agents. Hierarchical clustering analysis of the CFL1 gene network had the same robustness for stratified NSCLC patients. CONCLUSIONS: This study indicates that the CFL1 gene and its functional gene network can be used as prognostic biomarkers for NSCLC and could also guide chemotherapeutic interventions. Copyright (c) 2010 American Cancer Society.
BACKGROUND:Nonsmall cell lung cancer (NSCLC) is the major determinant of overall cancer mortality worldwide. Despite progress in molecular research, current treatments offer limited benefits. Because NSCLC generates early metastasis, and this behavior requires great cell motility, herein the authors assessed the potential value of CFL1 gene (main member of the invasion/metastasis pathway) as a prognostic and predictive NSCLC biomarker. METHODS: Metadata analysis of tumor tissue microarray was applied to examine expression of CFL1 in archival lung cancer samples from 111 patients, and its clinicopathologic significance was investigated. The robustness of the finding was validated using another independent data set. Finally, the authors assayed in vitro the role of CFL1 levels in tumor invasiveness and drug resistance using 6 humanNSCLC cell lines with different basal degrees of CFL1 gene expression. RESULTS:CFL1 levels in biopsies discriminate between good and bad prognosis at early tumor stages (IA, IB, and IIA/B), where high CFL1 levels are correlated with lower overall survival rate (P<.0001). Biomarker performance was further analyzed by immunohistochemistry, hazard ratio (P<.001), and receiver-operating characteristic curve (area=0.787; P<.001). High CFL1 mRNA levels and protein content are positively correlated with cellular invasiveness (determined by Matrigel Invasion Chamber System) and resistance (2-fold increase in drug 50% growth inhibition dose) against a list of 22 alkylating agents. Hierarchical clustering analysis of the CFL1 gene network had the same robustness for stratified NSCLCpatients. CONCLUSIONS: This study indicates that the CFL1 gene and its functional gene network can be used as prognostic biomarkers for NSCLC and could also guide chemotherapeutic interventions. Copyright (c) 2010 American Cancer Society.
Authors: U Scherf; D T Ross; M Waltham; L H Smith; J K Lee; L Tanabe; K W Kohn; W C Reinhold; T G Myers; D T Andrews; D A Scudiero; M B Eisen; E A Sausville; Y Pommier; D Botstein; P O Brown; J N Weinstein Journal: Nat Genet Date: 2000-03 Impact factor: 38.330
Authors: Weigang Wang; Sumanta Goswami; Kyle Lapidus; Amber L Wells; Jeffrey B Wyckoff; Erik Sahai; Robert H Singer; Jeffrey E Segall; John S Condeelis Journal: Cancer Res Date: 2004-12-01 Impact factor: 12.701
Authors: Andrew I Su; Tim Wiltshire; Serge Batalov; Hilmar Lapp; Keith A Ching; David Block; Jie Zhang; Richard Soden; Mimi Hayakawa; Gabriel Kreiman; Michael P Cooke; John R Walker; John B Hogenesch Journal: Proc Natl Acad Sci U S A Date: 2004-04-09 Impact factor: 11.205
Authors: Ahmedin Jemal; Limin X Clegg; Elizabeth Ward; Lynn A G Ries; Xiaocheng Wu; Patricia M Jamison; Phyllis A Wingo; Holly L Howe; Robert N Anderson; Brenda K Edwards Journal: Cancer Date: 2004-07-01 Impact factor: 6.860
Authors: David G Beer; Sharon L R Kardia; Chiang-Ching Huang; Thomas J Giordano; Albert M Levin; David E Misek; Lin Lin; Guoan Chen; Tarek G Gharib; Dafydd G Thomas; Michelle L Lizyness; Rork Kuick; Satoru Hayasaka; Jeremy M G Taylor; Mark D Iannettoni; Mark B Orringer; Samir Hanash Journal: Nat Med Date: 2002-07-15 Impact factor: 53.440
Authors: Carolina B Müller; Rafael L S de Barros; Mauro A A Castro; Fernanda M Lopes; Rosalva T Meurer; Adriana Roehe; Guilherme Mazzini; Jane Maria Ulbrich-Kulczynski; Felipe Dal-Pizzol; Marilda C Fernandes; José C F Moreira; Léder L Xavier; Fábio Klamt Journal: J Cancer Res Clin Oncol Date: 2011-07-08 Impact factor: 4.553
Authors: Sarah Strohkamp; Timo Gemoll; Sina Humborg; Sonja Hartwig; Stefan Lehr; Sandra Freitag-Wolf; Susanne Becker; Bo Franzén; Ralph Pries; Barbara Wollenberg; Uwe J Roblick; Hans-Peter Bruch; Tobias Keck; Gert Auer; Jens K Habermann Journal: Cell Mol Life Sci Date: 2017-08-28 Impact factor: 9.261
Authors: Leonardo Lisbôa da Motta; Carolina B Müller; Marco A De Bastiani; Guilherme A Behr; Fernanda S França; Ricardo F da Rocha; Juliane B Minotto; Rosalva T Meurer; Marilda C Fernandes; Adriana Roehe; Melissa M Markoski; Cristiano F Andrade; Mauro A A Castro; Fábio Klamt Journal: J Cancer Res Clin Oncol Date: 2014-01-22 Impact factor: 4.553
Authors: Vassilios N Kotiadis; Jane E Leadsham; Emma L Bastow; Aline Gheeraert; Jennafer M Whybrew; Martin Bard; Pekka Lappalainen; Campbell W Gourlay Journal: J Cell Sci Date: 2012-02-17 Impact factor: 5.285
Authors: Helen Aggelou; Panagiota Chadla; Sofia Nikou; Sofia Karteri; Ioannis Maroulis; Haralabos P Kalofonos; Helen Papadaki; Vasiliki Bravou Journal: Virchows Arch Date: 2018-01-19 Impact factor: 4.064
Authors: Veronica Seccia; Elena Navari; Elena Donadio; Claudia Boldrini; Federica Ciregia; Maurizio Ronci; Antonio Aceto; Iacopo Dallan; Antonio Lucacchini; Augusto Pietro Casani; Maria Rosa Mazzoni; Laura Giusti Journal: Head Neck Pathol Date: 2019-05-16